TSA Updates Policy to Allow Medical Cannabis on Flights Without Clear Guidelines
The TSA now allows medical cannabis in carry-on and checked luggage, but travelers face uncertainty as the agency offers no clear rules or instructions on compliance
Key Points
- 1TSA updated its policy to allow medical marijuana in carry-on and checked bags with 'Special Instructions.'
- 2The guidance page for medical marijuana lacks any actual instructions or documentation requirements
- 3The change follows a federal rescheduling order affecting only specific FDA-approved and state-licensed medical cannabis products
- 4TSA officers can still refer cannabis discoveries to local law enforcement, with state law determining the outcome
The Transportation Security Administration (TSA) has quietly updated its "What Can I Bring?" tool to indicate that medical marijuana is now permitted in both carry-on and checked bags, marking a significant shift in federal travel policy. This change coincided with the implementation of a narrow federal rescheduling order, which reclassified certain cannabis products as Schedule III substances under specific conditions. However, travelers seeking clarity on the exact requirements will find the TSA’s guidance page blank, with only the vague note of "Special Instructions" and no further explanation
According to High Times, the TSA’s online tool was modified on April 27, just before Acting Attorney General Todd Blanche’s rescheduling order took effect. The previous warning that marijuana is illegal under federal law has been removed, and the standard disclaimer now omits cannabis from the list of substances that TSA officers are not actively searching for. "The page no longer names cannabis as something officers aren’t looking for, because under the new federal posture, some of it isn’t illegal," High Times reports
Despite the policy update, the absence of detailed instructions leaves medical cannabis patients in a legal gray area. The TSA often uses "Special Instructions" to direct travelers to additional rules for items like firearms or lithium batteries, typically accompanied by specific guidelines or documentation requirements. In the case of medical marijuana, no such instructions or supporting documents are provided, creating confusion for those trying to comply with the law
The rescheduling order applies only to FDA-approved cannabis-derived medications and marijuana products regulated under a qualifying state medical license. This means that a Florida-licensed product with proper documentation may qualify as Schedule III, while recreational cannabis or products from states without a recognized medical program remain Schedule I and federally illegal. As High Times notes, "The legal status of the cannabis in your bag now depends on its paperwork."
Compounding the uncertainty, TSA officers still have the authority to refer any discovered cannabis to local law enforcement, whose response will depend on state laws. This patchwork of regulations poses particular risks for travelers passing through states like Florida, Georgia, and Texas, where unauthorized cannabis possession remains a serious offense. Black Cannabis Magazine highlighted that this enforcement gap disproportionately affects patients least able to navigate complex legal systems
From the OG Lab newsroom perspective, this policy shift is a historic but incomplete step for medical cannabis access in the United States. The lack of clear federal guidance leaves patients vulnerable to inconsistent enforcement and potential legal jeopardy. As broader rescheduling discussions continue, especially with the upcoming DEA hearing in June, the cannabis industry and its consumers will be watching closely for more comprehensive federal action and detailed regulatory clarity
